Lantheus Holdings (LNTH) Change in Receivables (2014 - 2026)

Lantheus Holdings' (LNTH) quarterly Change in Receivables came in at $2.2 million in Q1 2026, down 91.53% year-on-year from $26.4 million in Q1 2025, and up 7.98% on a QoQ basis from $2.1 million in Q4 2025.

Lantheus Holdings (LNTH) Change in Receivables (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has 13 years of Change in Receivables data on file, last reported at $2.2 million in Q1 2026.

  • On a quarterly basis, Change in Receivables fell 91.53% year-over-year to $2.2 million in Q1 2026; TTM through Mar 2026 was -$6.2 million, a 172.53% decrease from a year earlier, with the FY2025 full-year figure at $17.9 million, down 52.53% from the prior year.
  • Change in Receivables for Q1 2026 stood at $2.2 million, up from $2.1 million in the prior quarter.
  • Over the last five years, Change in Receivables for LNTH reached as high as $85.2 million in Q1 2022 and fell as low as -$43.1 million in Q3 2024.
  • Historically, Change in Receivables has averaged $15.0 million across 5 years, with a median of $14.4 million in 2023.
  • Across the five-year window, Change in Receivables jumped 3529.8% in 2022 and sank 1187.77% in 2024, its largest moves.
  • Year by year, Change in Receivables stood at $16.4 million in 2022, then surged by 55.78% to $25.6 million in 2023, then slumped by 128.14% to -$7.2 million in 2024, then jumped by 128.7% to $2.1 million in 2025, then climbed by 7.98% to $2.2 million in 2026.
  • Per Business Quant data, the three most recent Change in Receivables figures were $2.2 million in Q1 2026, $2.1 million in Q4 2025, and -$12.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -78.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 106.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -621.82 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -38.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 126.30 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 81.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Lantheus Holdings 6.72 Bn 6.22 Bn 230.92 Mn 2.23 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.23 Mn
Mar 31, 2026 2.23 Mn
Dec 31, 2025 2.07 Mn
Dec 31, 2025 2.07 Mn
Sep 30, 2025 -12.83 Mn
Sep 30, 2025 -12.83 Mn
Jun 30, 2025 2.29 Mn
Jun 30, 2025 2.29 Mn
Mar 31, 2025 26.36 Mn
Mar 31, 2025 26.36 Mn
Dec 31, 2024 -7.20 Mn
Dec 31, 2024 -7.20 Mn
Sep 30, 2024 -43.14 Mn
Sep 30, 2024 -43.14 Mn
Jun 30, 2024 32.59 Mn
Jun 30, 2024 32.59 Mn
Mar 31, 2024 55.44 Mn
Mar 31, 2024 55.44 Mn
Dec 31, 2023 25.59 Mn
Dec 31, 2023 25.59 Mn